Fat mass obesity-associated ( FTO ) (rs9939609) and melanocortin 4 receptor ( MC4R ) (rs17782313) SNP are positively associated with obesity and blood pressure in Mexican school-aged children
2016; Cambridge University Press; Volume: 116; Issue: 10 Linguagem: Inglês
10.1017/s0007114516003779
ISSN1475-2662
AutoresPablo García‐Solís, Reyes‐Bastidas Marissa, Karla Flores, Olga P. García, Jorge L. Rosado, Lorena Méndez-Villa, María Carlota García Gutiérrez, David Gustavo García-Gutiérrez, Aarón Kuri-García, Hebert Luis Hernández‐Montiel, Soriano‐Leon Ofelia, María Elena Villagrán-Herrera, Juan Carlos Solís‐S,
Tópico(s)Genetic Associations and Epidemiology
ResumoChildhood overweight and obesity are worldwide public health problems and risk factors for chronic diseases. The presence of SNP in several genes has been associated with the presence of obesity. A total of 580 children (8-13 years old) from Queretaro, Mexico, participated in this cross-sectional study, which evaluated the associations of rs9939609 (fat mass obesity-associated (FTO)), rs17782313 (melanocortin 4 receptor (MC4R)) and rs6548238 (transmembrane protein 18 (TMEM18)) SNP with obesity and metabolic risk factors. Overweight and obesity prevalence was 19·8 and 19·1 %, respectively. FTO, MC4R and TMEM18 risk allele frequency was 17, 9·8 and 89·5 %, respectively. A significant association between FTO homozygous and MC4R heterozygous risk alleles and obesity was found (OR 3·9; 95 % CI 1·46, 10·22, and OR 2·1; 95 % CI 1·22, 3·71; respectively). The FTO heterozygous subjects showed higher systolic and diastolic blood pressures, compared with the homozygous for the ancestral allele subjects. These results remain significant after considering adiposity as a covariate. The FTO and MC4R genotypes were not significantly associated with total cholesterol, HDL-cholesterol and insulin concentration. No association was found between TMEM18 risk allele and obesity and/or metabolic alterations. Our results show that, in addition to a higher BMI, there is also an association of the risk genotype with blood pressure in the presence of the FTO risk genotype. The possible presence of a risk genotype in obese children must be considered to offer a more comprehensive therapeutic approach in order to delay and/or prevent the development of chronic diseases.
Referência(s)